These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
889 related articles for article (PubMed ID: 32026478)
1. Development and validation of a nomogram for predicting cancer-specific survival of surgical resected stage I-II adenosquamous carcinoma of the lung. Li H; Wang Z; Yang F; Wang J J Surg Oncol; 2020 May; 121(6):1027-1035. PubMed ID: 32026478 [TBL] [Abstract][Full Text] [Related]
2. A competing risk nomogram predicting cause-specific mortality in patients with lung adenosquamous carcinoma. Wu X; Yu W; Petersen RH; Sheng H; Wang Y; Lv W; Hu J BMC Cancer; 2020 May; 20(1):429. PubMed ID: 32416716 [TBL] [Abstract][Full Text] [Related]
3. The role of surgery for atypical bronchopulmonary carcinoid tumor: Development and validation of a model based on Surveillance, Epidemiology, and End Results (SEER) database. Chen X; Pang Z; Wang Y; Bie F; Zeng Y; Wang G; Du J Lung Cancer; 2020 Jan; 139():94-102. PubMed ID: 31759223 [TBL] [Abstract][Full Text] [Related]
4. A nomogram to predict the survival of stage IIIA-N2 non-small cell lung cancer after surgery. Mao Q; Xia W; Dong G; Chen S; Wang A; Jin G; Jiang F; Xu L J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1784-1792.e3. PubMed ID: 29554790 [TBL] [Abstract][Full Text] [Related]
5. Development and validation of nomogram combining serum biomarker for predicting survival in patients with resected rectal cancer. Fan S; Li T; Zhou P; Peng Q; Zhu Y Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31693739 [TBL] [Abstract][Full Text] [Related]
6. A novel nomogram with preferable capability in predicting the overall survival of patients after radical esophageal cancer resection based on accessible clinical indicators: A comparison with AJCC staging. Li X; Xu J; Zhu L; Yang S; Yu L; Lv W; Hu J Cancer Med; 2021 Jul; 10(13):4228-4239. PubMed ID: 34128338 [TBL] [Abstract][Full Text] [Related]
7. A Nomogram for Predicting Cancer-Specific Survival of TNM 8th Edition Stage I Non-small-cell Lung Cancer. Zeng Y; Mayne N; Yang CJ; D'Amico TA; Ng CSH; Liu CC; Petersen RH; Rocco G; Brunelli A; Liu J; Liu Y; Huang W; He J; Wang W; Jiang L; Cui F; Wang W; Liang W; He J; Ann Surg Oncol; 2019 Jul; 26(7):2053-2062. PubMed ID: 30900105 [TBL] [Abstract][Full Text] [Related]
8. Development and validation of a nomogram to predict cancer-specific survival of uveal melanoma. Zeng Q; Yao Y; Zhao M BMC Ophthalmol; 2021 May; 21(1):230. PubMed ID: 34030647 [TBL] [Abstract][Full Text] [Related]
9. Prognostic nomogram predicts overall survival in pulmonary large cell neuroendocrine carcinoma. He Y; Liu H; Wang S; Chen Y PLoS One; 2019; 14(9):e0223275. PubMed ID: 31560723 [TBL] [Abstract][Full Text] [Related]
10. Development and validation of a nomogram for predicting survival in patients with resected non-small-cell lung cancer. Liang W; Zhang L; Jiang G; Wang Q; Liu L; Liu D; Wang Z; Zhu Z; Deng Q; Xiong X; Shao W; Shi X; He J J Clin Oncol; 2015 Mar; 33(8):861-9. PubMed ID: 25624438 [TBL] [Abstract][Full Text] [Related]
11. Development and Validation of a Nomogram Prognostic Model for Resected Limited-Stage Small Cell Lung Cancer Patients. Zeng Q; Li J; Tan F; Sun N; Mao Y; Gao Y; Xue Q; Gao S; Zhao J; He J Ann Surg Oncol; 2021 Sep; 28(9):4893-4904. PubMed ID: 33655361 [TBL] [Abstract][Full Text] [Related]
12. Effect of surgery on survival in patients with stage III N2 small cell lung cancer: propensity score matching analysis and nomogram development and validation. Chai Y; Ma Y; Feng W; Lu H; Jin L World J Surg Oncol; 2021 Aug; 19(1):258. PubMed ID: 34461929 [TBL] [Abstract][Full Text] [Related]
13. Development and Validation of a Nomogram-Based Prognostic Evaluation Model for Sarcomatoid Hepatocellular Carcinoma. Ge D; Luo Z; Mao R; Zhao H; Lv X; Zhao J; Zhou J; Huang Z; Zhang Y; Li Z; Bi X; Cai J Adv Ther; 2020 Jul; 37(7):3185-3205. PubMed ID: 32436026 [TBL] [Abstract][Full Text] [Related]
14. Construction and validation of prognostic nomograms for elderly patients with metastatic non-small cell lung cancer. Sun H; Liu M; Yang X; Ren Y; Dai H; Wang C Clin Respir J; 2022 May; 16(5):380-393. PubMed ID: 35514033 [TBL] [Abstract][Full Text] [Related]
15. Development and validation of nomogram prognostic model for early-stage T1-2N0M0 small cell lung cancer: A population-based analysis. Ge T; Zhu S; Sun L; Yin L; Dai J; Qian J; Chen X; Zhang P; Zhu J; Jiang G Front Oncol; 2022; 12():921365. PubMed ID: 36465408 [TBL] [Abstract][Full Text] [Related]
16. Nomogram to Predict Cancer Specific Survival in Patients with Pathological Stage IA Non-small Cell Lung Cancer. Cai JS; Dou XM; Li JB; Yang MZ; Xie CL; Hou X; Yang HX Semin Thorac Cardiovasc Surg; 2022; 34(3):1040-1048. PubMed ID: 34216749 [TBL] [Abstract][Full Text] [Related]
17. Significance of metastatic lymph nodes ratio in overall survival for patients with resected nonsmall cell lung cancer: a retrospective cohort study. Lin X; Yao J; Huang B; Chen T; Xie L; Huang R Eur J Cancer Prev; 2024 Jul; 33(4):376-385. PubMed ID: 38842873 [TBL] [Abstract][Full Text] [Related]
18. Nomogram predicting survival in patients with lymph node-negative hepatocellular carcinoma based on the SEER database and external validation. Li Z; Hong Q; Li K Eur J Gastroenterol Hepatol; 2024 Jul; 36(7):904-915. PubMed ID: 38652516 [TBL] [Abstract][Full Text] [Related]
19. Construction and Validation of a Novel Nomogram to Predict the Overall Survival of Patients With Combined Small Cell Lung Cancer: A Surveillance, Epidemiology, and End Results Population-Based Study. Jiang A; Liu N; Zhao R; Liu S; Gao H; Wang J; Zheng X; Ren M; Fu X; Liang X; Tian T; Ruan Z; Yao Y Cancer Control; 2021; 28():10732748211051228. PubMed ID: 34632799 [TBL] [Abstract][Full Text] [Related]
20. Development and validation of nomograms for predicting survival of elderly patients with stage I small-cell lung cancer. Yang Y; Sun S; Wang Y; Xiong F; Xiao Y; Huang J Bosn J Basic Med Sci; 2021 Oct; 21(5):632-641. PubMed ID: 33577444 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]